Though the results are preliminary, they suggest that a simpler method that doesn't require isolation of CTCs could potentially be as effective as current CTC-based approaches for AR-V7 testing.
Researchers saw abbreviated overall survival times in estrogen receptor-positive metastatic breast cancer patients with ESR1 mutations in their cell-free DNA.
The New York Times looks at immunotherapy and its use in cancer treatment.
In a cohort of more than 150 patients, none who responded well to anti-androgen therapy had AR-V7-positive circulating tumor cells detected by Epic's technology.
The partners will focus on microbiome drugs for cancer patients undergoing hematopoietic stem cell transplantation or receiving checkpoint inhibitors.
Some 20 percent of 650 clinical germlines analyzed since the project launched last year have had at least one variant associated with increased cancer risk.
The institute will combine expertise from six cancer centers in the US in order to drive research and drug development in cancer immunotherapy.
The data included results from thousands of clinically tested samples showing frequent identification of clinically useful diagnostic and prognostic markers.
The partners will evaluate the ability of ImmunID's ImmunTracker assay to predict the responses of patients with solid tumors to cancer immunotherapy.
Two separate studies concluded that in most SEO cancer cases what they are seeing are two separate early-stage tumors, instead of late-stage cancer.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.